6 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 4–6 mL QID or 1– ... antifungals are required ... candida #mucosal #IDSA ... opportunistic #infections
Bacteremia Quick Reference - Treatment Duration

Gram Negative Bacteremia:
 • Avoid: Aminoglycosides and tigecycline
 • Catheters should
Reference - Treatment ... removed in septic shock ... follow up cultures required ... of metastatic infection ... #Treatment #Management
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Toxic Megacolon, Shock ... Epidemiology: • #1 ... can be community-acquired ... Ileus, Megacolon, Shock ... 10 mg/kg IV x 1
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Purtilo (XLP) Acquired ... CMV, HHV8,...), Bacteria ... Histoplasmosis, candidiasis ... Unknown cause Treatment ... diagnosis #management #treatment
IDSA Recommendations for Treating Bartonella Infections in HIV-AIDS
Preferred Therapy
For Bacillary Angiomatosis, Peliosis Hepatis, Bacteremia, and Osteomyelitis:
IDSA Recommendations ... Peliosis Hepatis, Bacteremia ... q12h + gentamicin 1 ... Bartonellosis #IDSA ... #Prevention #Treatment
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
clinical forms: 1) ... Fluconazole SYSTEMIC CANDIDIASIS ... fever • Septic shock ... blood cultures Candidiasis ... colonization Candidiasis